A carregar...
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
HER3 is the third member of the human epidermal growth factor receptor (HER/EGFR) family, and unlike its other family members, is unique due to its minimal intrinsic kinase activity. As a result, HER3 has to interact with another receptor tyrosine kinase (RTK), such as EGFR or HER2, in order to acti...
Na minha lista:
| Publicado no: | Biol Proced Online |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6425631/ https://ncbi.nlm.nih.gov/pubmed/30930695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12575-019-0093-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|